Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1996 1
1998 2
2000 1
2001 3
2002 3
2004 2
2005 4
2006 2
2007 2
2009 3
2010 5
2011 4
2012 2
2013 4
2014 2
2015 2
2016 7
2017 8
2018 13
2019 8
2020 5
2021 13
2022 12
2023 7
2024 0

Text availability

Article attribute

Article type

Publication date

PubMed for id: 1747359

104 results

Results by year

Filters applied: . Clear all
Page 1
[EZH inhibitors in lymphoma therapy].
Ishitsuka K. Ishitsuka K. Rinsho Ketsueki. 2023;64(7):665-669. doi: 10.11406/rinketsu.64.665. Rinsho Ketsueki. 2023. PMID: 37544728 Japanese.
Mutations associated with progression in follicular lymphoma predict inferior outcomes at diagnosis: Alliance A151303.
Russler-Germain DA, Krysiak K, Ramirez C, Mosior M, Watkins MP, Gomez F, Skidmore ZL, Trani L, Gao F, Geyer S, Cashen AF, Mehta-Shah N, Kahl BS, Bartlett NL, Alderuccio JP, Lossos IS, Ondrejka SL, Hsi ED, Martin P, Leonard JP, Griffith M, Griffith OL, Fehniger TA. Russler-Germain DA, et al. Blood Adv. 2023 Sep 26;7(18):5524-5539. doi: 10.1182/bloodadvances.2023010779. Blood Adv. 2023. PMID: 37493986 Free PMC article.
Follicular Helper T-Cell-derived Nodal Lymphomas: Study of Histomorphologic, Immunophenotypic, Clinical, and RHOA G17V Mutational Profile.
Jain S, Goswami A, Lone MR, Ramteke P, Gogia A, Aggarwal M, Viswanathan GK, Kakkar D, Mandal T, Sharma A, Sahoo R, Baldia A, Sharma MC, Bakhshi S, Pramanik R, Dhawan R, Kumar L, Mallick S. Jain S, et al. Appl Immunohistochem Mol Morphol. 2023 Mar 1;31(3):172-180. doi: 10.1097/PAI.0000000000001105. Epub 2023 Feb 20. Appl Immunohistochem Mol Morphol. 2023. PMID: 36806188
Reduced Number of Thymoma CTLA4-Positive Cells Is Associated With a Higher Probability of Developing Myasthenia Gravis.
Álvarez-Velasco R, Dols-Icardo O, El Bounasri S, López-Vilaró L, Trujillo JC, Reyes-Leiva D, Suárez-Calvet X, Cortés-Vicente E, Illa I, Gallardo E. Álvarez-Velasco R, et al. Neurol Neuroimmunol Neuroinflamm. 2023 Jan 25;10(2):e200085. doi: 10.1212/NXI.0000000000200085. Print 2023 Mar. Neurol Neuroimmunol Neuroinflamm. 2023. PMID: 36697230 Free PMC article.
Investigation of the risk factors to predict cytokine release syndrome in relapsed or refractory B-cell acute lymphoblastic leukemia patients receiving IL-6 knocking down anti-CD19 chimeric antigen receptor T-cell therapy.
Gong WJ, Qiu Y, Li MH, Chen LY, Li YY, Yu JQ, Kang LQ, Sun AN, Wu DP, Yu L, Xue SL. Gong WJ, et al. Front Immunol. 2022 Aug 29;13:922212. doi: 10.3389/fimmu.2022.922212. eCollection 2022. Front Immunol. 2022. PMID: 36105799 Free PMC article. Clinical Trial.
104 results